PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22FDGRE4556053986!sodium thiosulfate — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D9904. PoP ended Jan 11, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Dms Pharmaceutical Group Inc
Recipient
Jan 11, 2022
PoP end
$120K
Obligated
$120K
Potential
325411
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dms Pharmaceutical Group Inc — $90

Contract facts

Federal
Contract numberSPE2DX22FDGRE
Also listed asSPE2DX15D9904-SPE2DX22FDGRE
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentDms Pharmaceutical Group Inc
CAGE1UNB0
UEIPX72BSBQTKJ3
NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DX15D9904
Place of performancePARK RIDGE IL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startDec 17, 2021
PoP end (current)Jan 11, 2022
Obligated$120K
Current value$120K
Potential value$120K

4556053986!SODIUM THIOSULFATE is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value $120K ($120K obligated). Current period of performance ends Jan 11, 2022. Place of performance: PARK RIDGE IL.

Recompete timing

Public
Past PoP end (1683 days ago)

Current PoP ended Jan 11, 2022 (1683 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc$737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies
Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%
Open full company profile

Related awards

Same parent · incumbent
SPE2D026F0120
8511978882!OTHER MEDICAL
$248K
Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DX22FDGRE?

SPE2DX22FDGRE (4556053986!sodium thiosulfate) is a Dla Troop Support award with a potential value of $120K, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX22FDGRE?

Dla Troop Support awarded SPE2DX22FDGRE to Dms Pharmaceutical Group Inc (potential $120K).

Who is the incumbent on SPE2DX22FDGRE?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint. The current period of performance ends Jan 11, 2022.

When does Dms Pharmaceutical Group Inc’s SPE2DX22FDGRE come up for recompete?

SCOUT tracks a period-of-performance end of Jan 11, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DX22FDGRE